Exhibit 99.1 TELA Bio Reports First Quarter 2024 Financial Results MALVERN, PA, May 9, 2024 -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today reported financial results for the first quarter ended March 31, 2024. Recent Highlights · Reported revenue of $16.6 million in the first quarter, representing growth of 39% over the prior year period of 2023; · Delivered the 13th consecutive quarter of at least 35% ...